Akari Therapeutics PLC (AKTX)
0.98
0.00 (0.00%)
USD |
NASDAQ |
Dec 26, 16:00
1.02
+0.04
(+4.08%)
After-Hours: 20:00
Akari Therapeutics Free Cash Flow: -14.84M for Sept. 30, 2024
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| DBV Technologies SA | -108.72M |
| Ascendis Pharma AS | -- |
| Cellectis SA | 60.38M |
| Adaptimmune Therapeutics PLC | -56.05M |
| Biodexa Pharmaceuticals PLC | -11.12M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -1.49M |
| Cash from Financing (Quarterly) | -0.443M |
| Free Cash Flow Per Share (Quarterly) | -0.1222 |
| Free Cash Flow Yield | -185.0% |